NO902393L - Dna som koder for ige-reseptor alfa-underenhet eller fragment derav. - Google Patents

Dna som koder for ige-reseptor alfa-underenhet eller fragment derav.

Info

Publication number
NO902393L
NO902393L NO90902393A NO902393A NO902393L NO 902393 L NO902393 L NO 902393L NO 90902393 A NO90902393 A NO 90902393A NO 902393 A NO902393 A NO 902393A NO 902393 L NO902393 L NO 902393L
Authority
NO
Norway
Prior art keywords
subunit
fragments
dna encoding
ige receptor
ige
Prior art date
Application number
NO90902393A
Other languages
English (en)
Other versions
NO310424B1 (no
NO902393D0 (no
Inventor
Reuben Siraganian
Akira Shimizu
Philip Leder
Philip Benfey
Original Assignee
Harvard College
Reuben Siraganian
Akira Shimizu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22428905&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO902393(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Harvard College, Reuben Siraganian, Akira Shimizu filed Critical Harvard College
Publication of NO902393L publication Critical patent/NO902393L/no
Publication of NO902393D0 publication Critical patent/NO902393D0/no
Publication of NO310424B1 publication Critical patent/NO310424B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
NO19902393A 1987-12-01 1990-05-30 cDNA som koder for IgE-reseptor <alfa>-underenhet eller fragment av denne, fremgangsmåte for fremstilling av löselig<alfa>-underenhet-polypeptid ved anvendelse av denne, samt vektorsom omfatter nevnte cDNA NO310424B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/127,214 US4962035A (en) 1987-12-01 1987-12-01 DNA encoding IgE receptor alpha-subunit or fragment thereof
PCT/US1988/004255 WO1989005352A1 (en) 1987-12-01 1988-11-29 DNA ENCODING IgE RECEPTOR alpha-SUBUNIT OR FRAGMENT THEREOF

Publications (3)

Publication Number Publication Date
NO902393L true NO902393L (no) 1990-05-30
NO902393D0 NO902393D0 (no) 1990-05-30
NO310424B1 NO310424B1 (no) 2001-07-02

Family

ID=22428905

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19902393A NO310424B1 (no) 1987-12-01 1990-05-30 cDNA som koder for IgE-reseptor <alfa>-underenhet eller fragment av denne, fremgangsmåte for fremstilling av löselig<alfa>-underenhet-polypeptid ved anvendelse av denne, samt vektorsom omfatter nevnte cDNA

Country Status (11)

Country Link
US (2) US4962035A (no)
EP (1) EP0394302B1 (no)
JP (1) JP3117206B2 (no)
KR (1) KR970009936B1 (no)
AT (1) ATE177148T1 (no)
AU (1) AU625434B2 (no)
CA (1) CA1341538C (no)
DE (1) DE3856309T2 (no)
DK (2) DK175974B1 (no)
NO (1) NO310424B1 (no)
WO (1) WO1989005352A1 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451669A (en) * 1986-05-29 1995-09-19 The University Of Melbourne DNA encoding for an Fc receptor for immunoglobulin
US5985599A (en) * 1986-05-29 1999-11-16 The Austin Research Institute FC receptor for immunoglobulin
US5639660A (en) 1988-02-24 1997-06-17 Hoffmann-La Roche Inc. Polypeptide and DNA sequence corresponding to the human receptor with high affinity for IgE
CA2059842A1 (en) * 1991-02-11 1992-08-12 Richard A. Chizzonite Ige-receptor-antibodies
US5516651A (en) * 1991-11-15 1996-05-14 The General Hospital Corporation Nucleic acids encoding calcitonin receptor and uses thereof
US5770396A (en) * 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
CA2141685A1 (en) * 1992-08-04 1994-02-17 Koji Naito Antiallergic composition
US5874404A (en) * 1992-08-04 1999-02-23 Chisei Ra Immunoglobulin E receptor α-chain inhibits IgE production and secondary allergic responses
EP0733207B1 (en) * 1993-12-10 1997-08-27 Genentech, Inc. Methods for diagnosis of allergy and screening of anti-allergy therapeutics
JP3825798B2 (ja) * 1994-01-18 2006-09-27 ジェネンテク，インコーポレイテッド ＩｇＥアンタゴニストを用いる寄生虫感染症の治療法
US6685940B2 (en) * 1995-07-27 2004-02-03 Genentech, Inc. Protein formulation
US20040197326A1 (en) * 1995-07-27 2004-10-07 Genentech, Inc. Method for treatment of allergic asthma
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
GB9526599D0 (en) 1995-12-28 1996-02-28 Sandoz Ltd Elisa test system
PE99498A1 (es) * 1996-07-26 1999-01-21 Novartis Ag Polipeptidos de fusion
US6423512B1 (en) 1996-07-26 2002-07-23 Novartis Ag Fusion polypeptides
US6391569B1 (en) 1996-09-18 2002-05-21 Heska Corporation Method to detect Dirofilaria immitis infection
US5945294A (en) 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
AU769954B2 (en) * 1996-11-26 2004-02-12 Heska Corporation Method to detect IgE
US5958880A (en) * 1996-12-19 1999-09-28 Heska Corporation Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof
US6060326A (en) * 1997-04-07 2000-05-09 Heska Corporation Method to detect canine IgE and kit therefor
US6057127A (en) * 1998-01-29 2000-05-02 Heska Corporation Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
CA2349410A1 (en) * 1998-11-05 2000-05-11 Heska Corporation Crystallized form of fc epsilon receptor alpha chain, its 3-d model and uses thereof
US6889145B1 (en) * 2000-03-15 2005-05-03 Northwestern University Three-dimensional model of a Fc region of an IgE antibody and uses thereof
AU2001245835A1 (en) * 2000-03-15 2001-09-24 Heska Corporation Three-dimensional model of a complex between a Fc epsilon receptor alpha chain and a Fc region of an IgE antibody and uses thereof
US20030022250A1 (en) * 2001-05-29 2003-01-30 Dreskin Stephen C. Functional IgE test methods and compositions
EP2284192A3 (en) 2002-11-08 2011-07-20 Ablynx N.V. Camelidae antibodies for sublingual administration
EP1558647B1 (en) 2002-11-08 2015-06-10 Ablynx N.V. Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
EP3192806A1 (en) 2016-01-13 2017-07-19 Affiris AG Alpha chain of the high-affinity ige receptor (fceria)
CN110716054A (zh) * 2019-09-11 2020-01-21 天津医科大学 一种血清亲细胞性免疫球蛋白e的定量检测试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6385886A (en) * 1986-10-10 1988-04-14 Medical Biology Institute Production of ige-binding protein by recombinant methods

Also Published As

Publication number Publication date
DE3856309T2 (de) 1999-07-15
DK175974B1 (da) 2005-10-10
DK134790D0 (da) 1990-05-31
EP0394302A4 (en) 1991-09-11
DK200500682A (da) 2005-05-11
CA1341538C (en) 2007-08-28
JP3117206B2 (ja) 2000-12-11
NO310424B1 (no) 2001-07-02
DE3856309D1 (de) 1999-04-08
US4962035A (en) 1990-10-09
EP0394302B1 (en) 1999-03-03
DK134790A (da) 1990-07-25
AU2610588A (en) 1989-07-05
DK176181B1 (da) 2006-12-11
ATE177148T1 (de) 1999-03-15
AU625434B2 (en) 1992-07-09
KR970009936B1 (ko) 1997-06-19
WO1989005352A1 (en) 1989-06-15
NO902393D0 (no) 1990-05-30
KR900700600A (ko) 1990-08-16
EP0394302A1 (en) 1990-10-31
JPH03502878A (ja) 1991-07-04
US7202333B1 (en) 2007-04-10

Similar Documents

Publication Publication Date Title
NO902393D0 (no) Dna som koder for ige-reseptor alfa-underenhet eller fragment derav.
DE3789273D1 (de) Kodierungssystem zur Reduktion der Redundanz.
DE69033710D1 (de) Sekretion vom mit Gamma-Interferon Signalpeptid gebundenen humänen Protein
FI874819L (fi) Human rekombinant endotelcell vaextfaktor.
FI873185L (fi) Nya peptider.
FI893517A0 (fi) Blad foer roterande graesklippningsmaskin eller liknande.
EP0776331A4 (en) HIGHER ORDER STRUCTURE AND BINDING OF PEPTIDE NUCLEIC ACIDS
IL81839A0 (en) Polypeptide,dna and its use
FI855141A7 (fi) Rekombinantti-DNA-vektoreita, jotka kykenevät ilmaisemaan apoaequoriinia.
FI874287L (fi) Nya lymfokinpeptider.
KR890005270A (ko) 재조합 종두 비루스
NO852290L (no) Toert og/eller vaatt en-atmosfaerisk undervannssystem.
DE3788334D1 (de) Additionsreaktion von Hydrosilanen mit ungesättigten Kohlenwasserstoffen.
DE3778010D1 (de) Rechnersystem mit moduskonvertierung von rechnerbefehlen.
FI885296L (fi) Rekombinant hiv-2 polypeptid.
FI860741A7 (fi) Magnetisk struktur foer att anvaendas i taendsystem eller motsvarande i motorsaog.
NO903118L (no) Kloning og ekspresjon av et protein som modulerer cellulaer respons overfor type i interferon.
DE3886517D1 (de) Menschlicher Prourokinase ähnliches Polypeptid.
ATE101199T1 (de) Rekombinante ligninase.
NO873512L (no) Human lav-affinitets fcepsilon-reseptor, isolering, rekombinant fremstilling og rensing av denne.
FR2581854B1 (fr) Appareil de decapage par action chimique et mecanique associees, des residus fibreux, mousses, lieges, colles, fixes sur les sols
FI885994L (fi) Kork foer en flaska eller motsvarande.
NO902926L (no) Peptid tilsvarende hiv-env 583-599, og analoger derav, samt anvendelser av peptidene.
NO863941L (no) Selvregulerende propelleranlegg.
NO880080D0 (no) Fremgangsmaate for isolering og rensing av p.faliciparum cs-proteinvaksine uttrykt i rekombinant e.coli.